ESC 365 - Introduction

ESC Premium Access

Introduction

Session: Towards the state-of-the-art potassium control in patients with heart failure: are we there yet? (EBAC accredited)

Topic: Treatment

Speaker: Professor S. Anker (Berlin, DE)

Supported by an unrestricted educational grant from AstraZeneca

Event: ESC CONGRESS 2019

Congress Session

About the speaker

Professor Stefan Anker

Charite Campus Virchow Clinic, Berlin (Germany)

116 presentations

3 followers

4 more presentations in this session

Chronicity and burden of hyperkalaemia in heart failure: an update.

Speaker: Professor M. Lainscak (Murska Sobota, SI)

Hyperkalaemia: a barrier to guideline-recommended RAASi therapy?

Speaker: Professor S. Anker (Berlin, DE)

The management of hyperkalaemia in heart failure: is there room for improvement?

Speaker: Doctor M. Kosiborod (Kansas City, US)

Towards the state-of-the-art potassium management in heart failure: opportunities and challenges.

Speaker: Professor S. Anker (Berlin, DE) Doctor M. Kosiborod (Kansas City, US) Professor M. Lainscak (Murska Sobota, SI)

Access the full session

Towards the state-of-the-art potassium control in patients with heart failure: are we there yet? (EBAC accredited)

Speakers: Professor S. Anker, Professor M. Lainscak, Professor S. Anker, Doctor M. Kosiborod, Professor S. Anker...

About the event

ESC CONGRESS 2019

31 August - 4 September 2019

Sessions Presentations

Congress

Related content

ESC Premium Access

Ticagrelor implementation in PCI-treated ACS patients

27 August 2021

ESC Premium Access

TWILIGHT-Stent: Ticagrelor Monotherapy According to Stent Type

27 August 2021

ESC Premium Access

Benefits of SGLT2-1/2 Inhibition on Heart Failure, Ischemic, and Kidney Endpoints

27 August 2021

This platform is supported by